Tofacitinib Impurity 393
- CAS2459302-82-8
- CatalogueRS-T041066
- FormulaC19H23N7O2
- MW381.43
On this page
Custom synthesis — structure on request
Product identification
| Product name | Tofacitinib Impurity 393 |
|---|---|
| Catalogue No. | RS-T041066 |
| CAS No. | 2459302-82-8 |
| Molecular formula | C19H23N7O2 |
| Molecular weight | 381.43 |
| Exact mass | 381.1913 (monoisotopic) |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Tofacitinib |
| Also known as | Tofacitinib Impurity O |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-T041066 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Tofacitinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-T041066
- Request a quotation for RS-T041066
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Tofacitinib
All 185 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Tofacitinib
IN STOCKRS-U046260Tofacitinib Impurity C(Citrate)
IN STOCKRS-T041030Tofacitinib Impurity D
IN STOCKRS-T041009Tofacitinib Impurity E
IN STOCKRS-T041018Tofacitinib Impurity G
IN STOCKRS-T041019Tofacitinib Impurity H
IN STOCKRS-T041062Tofacitinib Impurity J
IN STOCKRS-Z398ZATTofacitinib Impurity L
IN STOCKRS-T041037Tofacitinib Impurity M
IN STOCKRS-T041036Tofacitinib Impurity M (1812890-23-5)
IN STOCKRS-T041047Tofacitinib Impurity N
IN STOCKRS-T041025Tofacitinib Impurity N(Citrate)
IN STOCKRS-T041046Tofacitinib Impurity P
IN STOCKRS-T041058Tofacitinib Impurity Q
IN STOCKRS-T041033Tofacitinib Impurity Q (1675248-19-7)
IN STOCKRS-T041027Tofacitinib Impurity R
CUSTOM SYNTHESISRS-T041038Tofacitinib Impurity Y
CUSTOM SYNTHESISRS-T041054(3R,4S)-1-benzyl-4-methylpiperidin-3-ol 4-methylbenzenesulfonate
BACK ORDERRS-U019186(3R,4S)-Tofacitinib
IN STOCKRS-T041004(3S,4R) Tofacitinib Citrate
BACK ORDERRS-T041029(3S,4R)-Tofacitinib
IN STOCKRS-T041006(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
IN STOCKRS-Z397SDD(3S,4S)-3-((1H-indol-4-yl)(methyl)amino)-4-methylpiperidin-1-ol
IN STOCKRS-T041351(3S,4S)-Tofacitinib
IN STOCKRS-T0410051-[(tert-Butoxy)carbonyl]-2-ethylpyrrolidine-3-carboxylic Acid
CUSTOM SYNTHESISRS-U0169681-Benzyl-4-methyl-3-(methylamino)piperidine dihydrochloride
IN STOCKRS-P0034741-benzyl-n,4-dimethylpiperidin-3-amine
IN STOCKRS-Z412QHJ1-benzyl-N,4-dimethylpiperidin-3-imine
CUSTOM SYNTHESISRS-U005A3K3-(4-methyl-3-(methylamino)piperidin-1-yl)-3-oxopropanenitrile
IN STOCKRS-Z395J7K3-(Dimethylamino)isonicotinaldehyde
BACK ORDERRS-U0685073-Chloro-5H-pyrrolo[2,3-b]pyrazine
IN STOCKRS-U0600234-Amino-6-chloropyrimidine
IN STOCKRS-U0747484-methoxy-7H-pyrrolo[2,3-d]pyrimidine
IN STOCKRS-C0010684-methylpiperidin-3-amine
BACK ORDERRS-U0855624-methylpiperidin-3-ol
IN STOCKRS-U0859584-methylpiperidin-3-one
IN STOCKRS-U0859175,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity
CUSTOM SYNTHESISRS-T0410785H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-6,7-dihydro-
CUSTOM SYNTHESISRS-U0675576-amino-5-(2,2-diethoxyethyl)-2-mercaptopyrimidin-4-ol
IN STOCKRS-T0413316-amino-5-(2,2-diethoxyethyl)pyrimidin-4-ol
IN STOCKRS-T0413306-aminopyrimidin-4-ol
IN STOCKRS-T041329cis-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride (and enantiomer)
BACK ORDERRS-Z401IVMDiethyl 2-cyanosuccinate
IN STOCKRS-I516061Ethyl 3-amino-3-oxopropanoate
CUSTOM SYNTHESISRS-C058040Ethyl cyanoacetate
IN STOCKRS-I006004N,4-Dimethyl-1-benzyl-3-piperidinamine D3
CUSTOM SYNTHESISRS-Z400PHLN,4-dimethyl-1-nitrosopiperidin-3-amine
IN STOCKRS-N001457N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
CUSTOM SYNTHESISRS-Z412MYKN4-Methyl Piperidinyl-4,6-pyrimidinediamine
CUSTOM SYNTHESISRS-Z401CSVp-Toluenesulfonic anhydride
IN STOCKRS-P017354raceMic-Tasocitinib
CUSTOM SYNTHESISRS-Z396J2Prel-(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine Dihydrochloride
IN STOCKRS-P007265sodium 6-amino-2-mercaptopyrimidin-4-olate
CUSTOM SYNTHESISRS-T041328SODIUM P-TOLUENESULFONATE
CUSTOM SYNTHESISRS-U070521Tofacitinib (923036-28-6)
IN STOCKRS-T041197Tofacitinib Citrate Mixure of Diastereomers
IN STOCKRS-T041092Tofacitinib Formyl Impurity
IN STOCKRS-T041055Tofacitinib Impurity DT
IN STOCKRS-T041012Tofacitinib Impurity FD+DX
IN STOCKRS-I009095Tofacitinib Impurity N76
IN STOCKRS-T041094Tofacitinib Impurity TBA
IN STOCKRS-T041024Tofacitinib Related Substance 1
IN STOCKRS-T041090Tofacitinib-d3 Citrate
BACK ORDERRS-Z003WT2Tofacitinib-D3 Citrate
BACK ORDERRS-Z401GQBTofacitinib Impurity 3
IN STOCKRS-Z395J7ATofacitinib Impurity 8
IN STOCKRS-T095002Tofacitinib Impurity 10
IN STOCKRS-T041007Tofacitinib Impurity 11
CUSTOM SYNTHESISRS-T041042Tofacitinib Impurity 13
IN STOCKRS-T041011Tofacitinib Impurity 21
IN STOCKRS-T041065Tofacitinib Impurity 26
IN STOCKRS-T041382Tofacitinib Related Compound 26 HCl
IN STOCKRS-T041040Tofacitinib Impurity 31
CUSTOM SYNTHESISRS-T041421Tofacitinib Impurity 35
BACK ORDERRS-I001ASUTofacitinib Impurity 38
BACK ORDERRS-T041087Tofacitinib Impurity 45
CUSTOM SYNTHESISRS-T041085Tofacitinib Impurity 66
BACK ORDERRS-Z401IVNTofacitinib Impurity 89
CUSTOM SYNTHESISRS-U096674Tofacitinib Impurity 91 (16372-08-0)
IN STOCKRS-T041194Tofacitinib Impurity 92
CUSTOM SYNTHESISRS-I001BR3Tofacitinib Impurity 93
IN STOCKRS-T041053Tofacitinib Impurity 96
IN STOCKRS-T041050Tofacitinib Impurity 97 (1638499-35-0)
CUSTOM SYNTHESISRS-T041195Tofacitinib Impurity 98
IN STOCKRS-T041068Tofacitinib Impurity 103
BACK ORDERRS-T041384Tofacitinib Impurity 104
BACK ORDERRS-T041060Tofacitinib Impurity 109
CUSTOM SYNTHESISRS-T041031Tofacitinib Impurity 110
BACK ORDERRS-T041067Tofacitinib Impurity 123
IN STOCKRS-T041008Tofacitinib Impurity 125 HCl
IN STOCKRS-T041198Tofacitinib Impurity 128 HCl
IN STOCKRS-Z400MMCTofacitinib Impurity 133(Dihydrochloride)
IN STOCKRS-T041048Tofacitinib Impurity 134
BACK ORDERRS-T095001Tofacitinib Impurity 137
IN STOCKRS-T041021Tofacitinib Impurity 138
IN STOCKRS-T041013Tofacitinib Impurity 140
CUSTOM SYNTHESISRS-T041017Tofacitinib Impurity 140 (Bromide)
IN STOCKRS-T041016Tofacitinib Impurity 144
IN STOCKRS-Z401EWPTofacitinib Impurity 146
IN STOCKRS-T041079Tofacitinib Impurity 147
IN STOCKRS-T041082Tofacitinib Impurity 148
BACK ORDERRS-I001AU7Tofacitinib Impurity 149
CUSTOM SYNTHESISRS-T041032Tofacitinib Impurity 153
IN STOCKRS-T041022Tofacitinib Impurity 155(Hydrochloride)
IN STOCKRS-T041043Tofacitinib Impurity 163
CUSTOM SYNTHESISRS-I001B7XTofacitinib Impurity 170 Trifluoroacetate
CUSTOM SYNTHESISRS-T041390Tofacitinib Impurity 176
CUSTOM SYNTHESISRS-I001AJYTofacitinib Impurity 179 HCl
BACK ORDERRS-T041388Tofacitinib Impurity 180
IN STOCKRS-I001AWJTofacitinib Impurity 183
CUSTOM SYNTHESISRS-Z394M14Tofacitinib impurity 195
IN STOCKRS-I001830Tofacitinib Impurity 201
IN STOCKRS-I001A5STofacitinib Impurity 203
IN STOCKRS-I001BLYTofacitinib Impurity 214
IN STOCKRS-I001A1XTofacitinib Impurity 217
IN STOCKRS-I001BO3Tofacitinib Impurity 218
IN STOCKRS-I001AVMTofacitinib Impurity 221
CUSTOM SYNTHESISRS-I001A29Tofacitinib Impurity 232
IN STOCKRS-I001AJ9Tofacitinib Impurity 242
IN STOCKRS-T041186Tofacitinib Impurity 248
IN STOCKRS-I001715Tofacitinib Impurity 250
CUSTOM SYNTHESISRS-T041095Tofacitinib Impurity 251
CUSTOM SYNTHESISRS-I001877Tofacitinib Impurity 264
IN STOCKRS-T041081Tofacitinib Impurity 271
IN STOCKRS-T041074Tofacitinib Impurity 285
BACK ORDERRS-T041201Tofacitinib Impurity 303
IN STOCKRS-T041203Tofacitinib Impurity 312
IN STOCKRS-T041204Tofacitinib Impurity 313
IN STOCKRS-T041187Tofacitinib Impurity 317
IN STOCKRS-T041034Tofacitinib Impurity 320
IN STOCKRS-T041052Tofacitinib Impurity 321
IN STOCKRS-T041071Tofacitinib Impurity 322
IN STOCKRS-T041080Tofacitinib Impurity 323
IN STOCKRS-T041189Tofacitinib Impurity 324
BACK ORDERRS-T041190Tofacitinib Impurity 325
BACK ORDERRS-T041191Tofacitinib Impurity 326
BACK ORDERRS-T041193Tofacitinib Impurity 330
IN STOCKRS-T095003Tofacitinib Impurity 331
IN STOCKRS-T041199Tofacitinib Impurity 332
IN STOCKRS-T041200Tofacitinib Impurity 380
CUSTOM SYNTHESISRS-T041002Tofacitinib Impurity 381
IN STOCKRS-T041003Tofacitinib Impurity 382
IN STOCKRS-T041010Tofacitinib Impurity 384
IN STOCKRS-T041020Tofacitinib Impurity 385
IN STOCKRS-T041026Tofacitinib Impurity 387
CUSTOM SYNTHESISRS-T041045Tofacitinib Impurity 389
BACK ORDERRS-T041051Tofacitinib Impurity 390
IN STOCKRS-T041059Tofacitinib Impurity 391
IN STOCKRS-T041061Tofacitinib Impurity 392
CUSTOM SYNTHESISRS-T041063Tofacitinib Impurity 394
BACK ORDERRS-T041070Tofacitinib Impurity 396
IN STOCKRS-T041073Tofacitinib Impurity 397
CUSTOM SYNTHESISRS-T041075Tofacitinib Impurity 398
IN STOCKRS-T041077Tofacitinib Impurity 399
IN STOCKRS-T041083Tofacitinib Impurity 400
IN STOCKRS-T041084Tofacitinib Impurity 401
IN STOCKRS-T041086Tofacitinib Impurity 402
IN STOCKRS-T041091Tofacitinib Impurity 403
IN STOCKRS-T041096Tofacitinib Impurity 423
IN STOCKRS-T041192Tofacitinib Impurity 424
CUSTOM SYNTHESISRS-T041196Tofacitinib Impurity 425
IN STOCKRS-T041202Tofacitinib Impurity 456
IN STOCKRS-T041188
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.

















![Chemical structure of (3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-ol](/structures/w4/GZVGGNOCKBKBJH-KOLCDFICSA-N.webp?v=11)







![Chemical structure of 1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione](/structures/w4/CFVCYPAWDKDZTI-VKGYTVAMSA-N.webp?v=11)
![Chemical structure of 1-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethan-1-one](/structures/w4/FJIVGKFVGCGMFC-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 1-[(tert-Butoxy)carbonyl]-2-ethylpyrrolidine-3-carboxylic Acid](/structures/w4/DCNSLQDWJVZTBS-UHFFFAOYSA-N.webp?v=11)



![Chemical structure of 2-chloro-1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone](/structures/w4/ASZSULBJLPUOKW-PWSUYJOCSA-N.webp?v=11)

![Chemical structure of 2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide](/structures/w4/OIWWCVOSVGSCLY-YPMHNXCESA-N.webp?v=11)
![Chemical structure of 2-methoxy-1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethan-1-one](/structures/w4/IVGPQZDYZWHBPG-YPMHNXCESA-N.webp?v=11)
![Chemical structure of 3-((3R,4R)-3-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/structures/w4/RINVSZVUBKMZHU-PWSUYJOCSA-N.webp?v=11)
![Chemical structure of 3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/structures/w4/FIQMDRYZOUHVEZ-PWSUYJOCSA-N.webp?v=11)
![Chemical structure of 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/structures/w4/WZSHBRMUAGEXTG-XLIONFOSSA-N.webp?v=11)
![Chemical structure of 3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-3,6-dihydropyridin-1(2H)-yl)-3-oxopropanenitrile](/structures/w4/JELREWKAMBPECC-UHFFFAOYSA-N.webp?v=11)


![Chemical structure of 3-Chloro-5H-pyrrolo[2,3-b]pyrazine](/structures/w4/QWTQGZAUKADLTO-UHFFFAOYSA-N.webp?v=11)

![Chemical structure of 4-methoxy-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/QGJOWBMQGBHKRM-UHFFFAOYSA-N.webp?v=11)



![Chemical structure of 5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity](/structures/w4/NCIZQRMMYUHTDP-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of 5H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-6,7-dihydro-](/structures/w4/NJYXRIIEMJOTRJ-UHFFFAOYSA-N.webp?v=11)



![Chemical structure of Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/structures/w4/IQFJFTIXSPNYQX-ZBFHGGJFSA-N.webp?v=11)


![Chemical structure of Ethanone, 2,2'-iminobis[1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-](/structures/w4/JCBCKCQTUVIZAH-FORRIVCFSA-N.webp?v=11)

![Chemical structure of ethyl 4-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-4-oxobutanoate](/structures/w4/ASXCOFXVKSZWRV-HIFRSBDPSA-N.webp?v=11)



![Chemical structure of N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/OJDQYIFUWQYHLW-PBHICJAKSA-N.webp?v=11)
![Chemical structure of N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/UXRJGSJDNLCQJQ-APWZRJJASA-N.webp?v=11)
![Chemical structure of N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-nitroso-7H-pyrrolo[2,3-d] pyrimidin-4-amine](/structures/w4/YUXGZYWWOSXMPX-QAPCUYQASA-N.webp?v=11)
![Chemical structure of N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/structures/w4/KBJLXQFINUUIBY-CFILVAQYSA-N.webp?v=11)
![Chemical structure of N-(1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/UMWNXPTXDOVDFE-UHFFFAOYSA-N.webp?v=11)
![Chemical structure of N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/XRIARWQZLGCQDM-ONGXEEELSA-N.webp?v=11)
![Chemical structure of N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/structures/w4/XRIARWQZLGCQDM-MWLCHTKSSA-N.webp?v=11)
![Chemical structure of N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine Hydrochloride](/structures/w4/CJRKOJYCZNKFRI-XQKZEKTMSA-N.webp?v=11)





![Chemical structure of tert-butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/structures/w4/ZGOLHNZTKPVOFZ-HIFRSBDPSA-N.webp?v=11)































































































